U.S. Capital Wealth Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-23
Closed -$1.37K – 804
2022
Q4
$1.37K Buy
+23
New +$1.78K ﹤0.01% 1515

Other funds holding CNBS

U.S. Capital Wealth Advisors's CNBS Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Amplify Seymour Cannabis ETF (CNBS) in Q1 2023, closing a stake of 23 shares — an estimated $1.37K sold.

U.S. Capital Wealth Advisors first reported a position in CNBS in Q4 2022 and held it in 1 quarter. The position peaked at $1.37K in Q4 2022. 32 funds tracked by Wall St. Rank hold CNBS as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Amplify Seymour Cannabis ETF position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 23 Amplify Seymour Cannabis ETF shares in Q1 2023, an estimated $1.37K.
  • U.S. Capital Wealth Advisors first reported a position in Amplify Seymour Cannabis ETF in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Amplify Seymour Cannabis ETF position peaked at $1.37K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.